Ahmed Salar A, Hameed Sazgar A, Hussen Bashdar M, Salihi Abbas
Department of Clinical Biochemistry, College of Medicine, Hawler Medical University, Erbil, Iraq.
Central laboratory, Hawler Teaching Hospital, Erbil, Iraq.
J Cardiovasc Thorac Res. 2020;12(3):227-230. doi: 10.34172/jcvtr.2020.39. Epub 2020 Sep 3.
Ischemic stroke is characterized as a sudden neurological deficit attributed to an acute focal injury of the central nervous system by a vascular cause. This study was performed to determine the frequency of G20210A mutation in the prothrombin gene and its effectiveness on the incidence of ischemic stroke in the Erbil city of Kurdistan region, Iraq. A total of 50 patients with ischemic stroke was analyzed for the detection of prothrombin gene mutation (G20210A), using polymerase chain reaction (PCR), Restriction fragment length polymorphism (RFLP) with Hind III restriction enzyme. We observed no evidence of an association between ischemic stroke and G20210A mutation in the prothrombin gene in this region. Our finding demonstrates that prothrombotic gene variant seems not to be linked to the incidence of ischemic stroke in Erbil region.
缺血性中风的特征是由于血管原因导致中枢神经系统急性局灶性损伤而引起的突发性神经功能缺损。本研究旨在确定伊拉克库尔德斯坦地区埃尔比勒市凝血酶原基因中G20210A突变的频率及其对缺血性中风发病率的影响。使用聚合酶链反应(PCR)、限制性片段长度多态性(RFLP)和Hind III限制性内切酶,对50例缺血性中风患者进行了凝血酶原基因突变(G20210A)检测分析。我们未观察到该地区缺血性中风与凝血酶原基因G20210A突变之间存在关联的证据。我们的研究结果表明,促血栓形成基因变异似乎与埃尔比勒地区缺血性中风的发病率无关。